Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Julio Lorenzi and Michel Nussenzweig.
Julio Lorenzi
Connection Strength
1.904
Michel Nussenzweig
  1. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021 03; 591(7851):639-644.
    View in: PubMed
    Score: 0.231
  2. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci Transl Med. 2021 01 20; 13(577).
    View in: PubMed
    Score: 0.229
  3. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 08; 584(7821):437-442.
    View in: PubMed
    Score: 0.222
  4. Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature. 2018 09; 561(7724):479-484.
    View in: PubMed
    Score: 0.197
  5. Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117. J Exp Med. 2018 09 03; 215(9):2311-2324.
    View in: PubMed
    Score: 0.195
  6. Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells. J Virol. 2018 03 01; 92(5).
    View in: PubMed
    Score: 0.189
  7. Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo. Cell. 2017 Aug 10; 170(4):637-648.e10.
    View in: PubMed
    Score: 0.182
  8. Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice. Nature. 2021 Sep; 597(7874):E2.
    View in: PubMed
    Score: 0.060
  9. Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques. PLoS Pathog. 2021 07; 17(7):e1009688.
    View in: PubMed
    Score: 0.060
  10. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021 07; 595(7866):278-282.
    View in: PubMed
    Score: 0.059
  11. Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice. Nature. 2021 05; 593(7859):424-428.
    View in: PubMed
    Score: 0.059
  12. Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo. J Exp Med. 2021 03 01; 218(3).
    View in: PubMed
    Score: 0.058
  13. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. 2020 11 02; 217(11).
    View in: PubMed
    Score: 0.057
  14. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 2020 10 28; 9.
    View in: PubMed
    Score: 0.057
  15. Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption. Proc Natl Acad Sci U S A. 2018 11 27; 115(48):E11341-E11348.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.